Tuesday, January 09, 2007 7:30:00 AM PDT | VentureDeal Staff
MD -- Sequoia Pharmaceuticals, Inc.
announced that it has raised $35 million in a series C round of financing led by
The Wellcome Trust.
Additional investors included Sofinnova Partners, Aberdare Ventures, Healthcare Ventures and new
investor MedImmune Ventures.
The company intends to use the funding proceeds to further develop its pipeline
of candidates for treatment of drug-resistant HIV infections, which include an
HIV protease inhibitor and a Pharmacokinetic Enhancer.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
Founded in 2006, VentureDeal is a database that provides the latest information about venture capital firms, venture-backed technology companies and transactions throughout North America.
Learn More »
Email Sign Up
© 2014 VentureDeal, Inc., Menlo Park, CA. All Rights Reserved.